CASP1 and Alzheimer disease: In the study by Chang, K.H.; et al., iPSCs were generated from familial AD patients with Amyloid precursor protein gene mutations exhibiting hallmark pathological changes—elevated Aβ42 levels, reduced synaptophysin expression, and increased caspase 1 activation—all characteristic of AD neurodegeneration [189].